During the past decade, Tennessee Oncology, PLLC,5653 First Blvd. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology, PLLC,5653 First Blvd." #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tennessee Oncology, PLLC,5653 First Blvd." are "Triple Negative Breast Cancer" (2 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Tennessee Oncology, PLLC,5653 First Blvd." in a lesser frequency.

Most popular intervention types in "Tennessee Oncology, PLLC,5653 First Blvd." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tennessee Oncology, PLLC,5653 First Blvd." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tennessee Oncology, PLLC,5653 First Blvd.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tennessee Oncology, PLLC,5653 First Blvd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tennessee Oncology, PLLC,5653 First Blvd., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".